Deuterium Metabolic Imaging Reports on TERT Expression and Early Response to Therapy in Cancer
Open accessPublished version of a preprint
The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Abstract
PURPOSE: Telomere maintenance is a hallmark of cancer. Most tumors maintain telomere length via reactivation of telomerase reverse transcriptase (TERT) expression. Identifying clinically translatable imaging biomarkers of TERT can enable noninvasive assessment of tumor proliferation and response to therapy. EXPERIMENTAL DESIGN: We used RNAi, doxycycline-inducible expression systems, and pharmacologic inhibitors to mechanistically delineate the association between TERT and metabolism in preclinical patient-derived tumor models. Deuterium magnetic resonance spectroscopy (2H-MRS), which is a novel, translational metabolic imaging modality, was used for imaging TERT in cells and tumor-bearing mice in vivo. RESULTS: Our results indicate that TERT expression is associated with elevated NADH in multiple cancers, including glioblastoma, oligodendroglioma, melanoma, neuroblastoma, and hepatocellular carcinoma. Mechanistically, TERT acts via the metabolic regulator FOXO1 to upregulate nicotinamide phosphoribosyl transferase, which is the key enzyme for NAD+ biosynthesis, and the glycolytic enzyme glyceraldehyde-3-phosphate dehydrogenase, which converts NAD+ to NADH. Because NADH is essential for pyruvate flux to lactate, we show that 2H-MRS-based assessment of lactate production from [U-2H]-pyruvate reports on TERT expression in preclinical tumor models in vivo, including at clinical field strength (3T). Importantly, [U-2H]-pyruvate reports on early response to therapy in mice bearing orthotopic patient-derived gliomas at early timepoints before radiographic alterations can be visualized by MRI. CONCLUSIONS: Elevated NADH is a metabolic consequence of TERT expression in cancer. Importantly, [U-2H]-pyruvate reports on early response to therapy, prior to anatomic alterations, thereby providing clinicians with a novel tool for assessment of tumor burden and treatment response in cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“hTERT also functionally interacts with FOXO1 to transactivate nicotinamide phosphoribosyl transferase, which catalyzes NAD + biosynthesis, and glyceraldehyde-3-phosphate dehydrogenase, which catalyzes the reduction of NAD + to NADH, thereby boosting cellular bioenergetics.131”
From Meta-hallmarks of aging and cancer (2023) · cites this paper as [131]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Modulation of oxidative stress as an anticancer strategy
Gorrini, C., Harris, I. S., & Mak, T. W. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4002 · Cited by 3,579 · cited 1×
“The redox environment of mammalian cells is regulated by levels of redox-reactive small molecules including GSH, GSSG, NADPH, NADP+, NADH and NAD+ (36).”
EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood
Weller, M., van den Bent, M., Preusser, M., Le Rhun, E., Tonn, J. C., Minniti, G., Bendszus, M., Balana, C., Chinot, O., Dirven, L., et al. (2021) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-00447-z · Cited by 2,048 · cited 1×
“We, therefore, examined whether [U-2 H]-pyruvate reports on response to TMZ, which is an alkylating chemotherapeutic that is standard of care for glioma patients (45).”
Williamson, D., Lund, P., & Krebs, H. (1967) · Biochemical Journal · doi:10.1042/bj1030514 · Cited by 1,871 · cited 1×
“Lactate production from pyruvate is directly dependent on NADH and has long been used as a surrogate for interrogating NADH and the NADH/NAD+ ratio in cell extracts (40,41).”
Metabolic Imaging of Patients with Prostate Cancer Using Hyperpolarized [1- 13 C]Pyruvate
Nelson, S. J., Kurhanewicz, J., Vigneron, D. B., Larson, P. E. Z., Harzstark, A. L., Ferrone, M., van Criekinge, M., Chang, J. W., Bok, R., Park, I., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3006070 · Cited by 1,286 · cited 1×
“Studies with hyperpolarized [1-13 C]-pyruvate have also established the safety of intravenous pyruvate administration in patients (47,50).”
NAD+ metabolism: pathophysiologic mechanisms and therapeutic potential
Xie, N., Zhang, L., Gao, W., Huang, C., Huber, P. E., Zhou, X., Li, C., Shen, G., & Zou, B. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00311-7 · Cited by 1,052 · cited 2×
“In contrast, supplementation with tryptophan or nicotinic acid, which are precursors for de novo biosynthesis (27,37), did not rescue NAD+ and NADH in TERT− cells (Supplementary Fig.”
Telomeres and telomerase: three decades of progress
Shay, J. W., & Wright, W. E. (2019) · Nature Reviews Genetics · doi:10.1038/s41576-019-0099-1 · Cited by 924 · cited 5×
“Telomerase reverse transcriptase (TERT) is the catalytic component of the enzyme telomerase that synthesizes telomeric DNA, and its expression is silenced in normal somatic cells, except stem cells (1,2).”
InfluentialDay, S. E., Kettunen, M. I., Gallagher, F. A., Hu, D.-E., Lerche, M., Wolber, J., Golman, K., Ardenkjaer-Larsen, J. H., & Brindle, K. M. (2007) · Nature Medicine · doi:10.1038/nm1650 · Cited by 883 · cited 1×
“Lactate production from pyruvate is directly dependent on NADH and has long been used as a surrogate for interrogating NADH and the NADH/NAD+ ratio in cell extracts (40,41).”
Negative Regulation of the Forkhead Transcription Factor FKHR by Akt
Tang, E. D., Nuñez, G., Barr, F. G., & Guan, K.-L. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.24.16741 · Cited by 761 · cited 4×
“CA-FOXO1 is a FLAG-tagged form of FOXO1 that is constitutively active since all three phosphorylation sites have been mutated to alanine (39).”
InfluentialMultiple High-Throughput Analyses Monitor the Response of E. coli to Perturbations
Ishii, N., Nakahigashi, K., Baba, T., Robert, M., Soga, T., Kanai, A., Hirasawa, T., Naba, M., Hirai, K., Hoque, A., et al. (2007) · Science · doi:10.1126/science.1132067 · Cited by 674 · cited 1×
“Steady-state metabolite levels, however, do not accurately reflect the activity of a metabolic pathway and may not be sensitive to fluctuations in concentrations of cofactors such as NADH (19).”
The transcription factor GABP selectively binds and activates the mutant TERT promoter in cancer
Bell, R. J. A., Rube, H. T., Kreig, A., Mancini, A., Fouse, S. D., Nagarajan, R. P., Choi, S., Hong, C., He, D., Pekmezci, M., et al. (2015) · Science · doi:10.1126/science.aab0015 · Cited by 566
Self-citation
Cited by
Meta-hallmarks of aging and cancer
López-Otín, C., Pietrocola, F., Roiz-Valle, D., Galluzzi, L., & Kroemer, G. (2023) · Cell Metabolism · doi:10.1016/j.cmet.2022.11.001 · Cited by 529
Metabolic imaging with deuterium labeled substrates
Low, J. C. M., Wright, A. J., Hesse, F., Cao, J., & Brindle, K. M. (2023) · Progress in Nuclear Magnetic Resonance Spectroscopy · doi:10.1016/j.pnmrs.2023.02.002 · Cited by 50
Montrazi, E. T., Sasson, K., Agemy, L., Scherz, A. J., & Frydman, L. (2024) · Science Advances · doi:10.1126/sciadv.adm8600 · Cited by 34
“Note that none of our experiments evidenced a peak at 1.4 to 1.5 ppm, which could have been ascribed to deuterated alanine—an alternative byproduct of pyruvate via transamination ( 28 ).”
InfluentialAdamson, P. M., Datta, K., Watkins, R., Recht, L. D., Hurd, R. E., & Spielman, D. M. (2023) · Magnetic Resonance in Medicine · doi:10.1002/mrm.29830 · Cited by 31
“47 If successfully demonstrated, DMI at 3T would accelerate clinical translation due to the ubiquity of clinical 3T scanners.”
BackgroundAdvances and prospects in deuterium metabolic imaging (DMI): a systematic review of in vivo studies
Pan, F., Liu, X., Wan, J., Guo, Y., Sun, P., Zhang, X., Wang, J., Bao, Q., & Yang, L. (2024) · European Radiology Experimental · doi:10.1186/s41747-024-00464-y · Cited by 28
Metadata
- Authors
- Batsios, G., Taglang, C., Tran, M., Stevers, N., Barger, C., Gillespie, A. M., Ronen, S. M., Costello, J. F., & Viswanath, P.
- Affiliations
- University of California, San Francisco (US)
- Corresponding author
- Viswanath, Pavithra
- ORCID
- Venue
- Clinical Cancer Research
- Published
- 2022-06-09
- Volume
- 28
- Issue
- 16
- Pages
- 3526-3536
- ISSN
- 1078-0432 (ISSN-L)
- 1557-3265
- PMC
- PMC9378519
- OpenAlex
- W4281814772
- Cited by
- 40
- References
- 50
- Citations by year
- 2026: 5 · 2025: 9 · 2024: 14 · 2023: 9 · 2022: 3
- FWCI
- 3.69
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Clinical Cancer Research (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- U.S. Department of Defense (W81XWH201055315)
- National Institutes of Health
- University of California, San Francisco (P30CA082103)
- National Cancer Institute (R01CA239288, F31CA254067, P30CA082103, P01CA118816, P50CA097257)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Physical Sciences › Chemistry › Spectroscopy › Advanced NMR Techniques and Applications
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Keywords
- telomerase reverse transcriptase, NADH, NAD biosynthesis, visfatin, FOXO1, glyceraldehyde-3-phosphate dehydrogenase, cancer metabolism, early treatment response, glioblastoma, patient-derived tumor models, imaging biomarkers
- MeSH terms
- Animals, Deuterium, Glioblastoma, NAD, Telomerase, Pyruvic Acid, Lactic Acid, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Deuterium Metabolic Imaging Reports on TERT Expression and Early Response to Therapy in Cancer. https://app.cochat.ai/papers/10.1158/1078-0432.ccr-21-4418
- The paper
- Batsios, G., Taglang, C., Tran, M., Stevers, N., Barger, C., Gillespie, A. M., Ronen, S. M., Costello, J. F., & Viswanath, P. (2022). Deuterium Metabolic Imaging Reports on TERT Expression and Early Response to Therapy in Cancer. Clinical Cancer Research. https://doi.org/10.1158/1078-0432.ccr-21-4418
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.